The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Movement Disorder Society Task Force report on the Hoehn and Yahr staging scale: Status and recommendations The Movement Disorder Society Task Force on rating scales for Parkinson's disease
Abstract
The Movement Disorder Society Task Force for Rating Scales for Parkinson's disease (PD) prepared a critique of the Hoehn and Yahr scale (HY). Strengths of the HY scale include its wide utilization and acceptance. Progressively higher stages correlate with neuroimaging studies of dopaminergic loss, and high correlations exist between the HY scale and some standardized scales of motor impairment, disability, and quality of life. Weaknesses include the scale's mixing of impairment and disability and its non‐linearity. Because the HY scale is weighted heavily toward postural instability as the primary index of disease severity, it does not capture completely impairments or disability from other motor features of PD and gives no information on nonmotor problems. Direct clinimetric testing of the HY scale has been very limited, but the scale fulfills at least some criteria for reliability and validity, especially for the midranges of the scale (Stages 2–4). Although a “modified HY scale” that includes 0.5 increments has been adopted widely, no clinimetric data are available on this adaptation. The Task Force recommends that: (1) the HY scale be used in its original form for demographic presentation of patient groups; (2) when the HY scale is used for group description, medians and ranges should be reported and analysis of changes should use nonparametric methods; (3) in research settings, the HY scale is useful primarily for defining inclusion/exclusion criteria; (4) to retain simplicity, clinicians should “rate what you see” and therefore incorporate comorbidities when assigning a HY stage; and (5) because of the wide usage of the modified HY scale with 0.5 increments, this adaptation warrants clinimetric testing. Without such testing, however, the original five‐point scales should be maintained. © 2004 Movement Disorder Society
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Parkinsonism: onset, progression, and mortality
Hoehn, M. M., & Yahr, M. D. (1967) · Neurology · doi:10.1212/wnl.17.5.427 · Cited by 12,107
Self-citation(1976) · Medical Entomology and Zoology · Cited by 8,899
Recent developments in Parkinson's disease
Fahn, S., Elton, R., MARSDEN, C. D., Calne, D. B., & Goldstein, M. (1986) · Raven Press eBooks · Cited by 2,306
Recent Developments in Parkinson's Disease
Hurtig, H. I. (1987) · Neurology · doi:10.1212/wnl.37.5.893 · Cited by 1,920
The Unified Parkinson's Disease Rating Scale (UPDRS): Status and recommendations
Movement Disorder Society Task Force on Rating Scales for Parkinson's Disease (2003) · Movement Disorders · doi:10.1002/mds.10473 · Cited by 1,810
JENKINSON, C., FITZPATRICK, R., PETO, V., GREENHALL, R., & HYMAN, N. (1997) · Age and Ageing · doi:10.1093/ageing/26.5.353 · Cited by 1,321
Variable expression of Parkinson's disease: A base‐line analysis of the DAT ATOP cohort
Jankovic, J., McDermott, M., Carter, J., Gauthier, S., Goetz, C., Golbe, L., Huber, S., Koller, W., Olanow, C., Shoulson, I., et al. (1990) · Neurology · doi:10.1212/wnl.40.10.1529 · Cited by 1,285
Self-citationPramipexole vs Levodopa as initial treatment for Parkinson disease: A randomized controlled trial
Holloway, R. G., Shoulson, I., Kieburtz, K. D., McDermott, M., Tariot, P. N., Kamp, C., Day, D., Shinaman, A., Fahn, S., Lang, A. E., et al. (2000) · JAMA · Cited by 798
Self-citationUnified Parkinson's disease rating scale characteristics and structure
Martínez‐Martín, P., Gil‐Nagel, A., Gracia, L. M., Gómez, J. B., Martínez‐Sarriés, J., Bermejo, F., & The Cooperative Multicentric Group (1994) · Movement Disorders · doi:10.1002/mds.870090112 · Cited by 796
The Prevention of Acute Gastric Ulcer in the Rat by α-Methyldopa
Djahanguiri, B., Hemmati, S., Sadeghi, D., & Firouzabadi, A. (1967) · Pharmacology · doi:10.1159/000137111 · Cited by 783
Cited by
Dorsey, E. R., Elbaz, A., Nichols, E., Abbasi, N., Abd-Allah, F., Abdelalim, A., Adsuar, J. C., Ansha, M. G., Brayne, C., Choi, J.-Y. J., et al. (2018) · The Lancet Neurology · doi:10.1016/s1474-4422(18)30295-3 · Cited by 2,816
Gut microbiota are related to Parkinson's disease and clinical phenotype
Scheperjans, F., Aho, V., Pereira, P. A. B., Koskinen, K., Paulin, L., Pekkonen, E., Haapaniemi, E., Kaakkola, S., Eerola‐Rautio, J., Pohja, M., et al. (2015) · Movement Disorders · doi:10.1002/mds.26069 · Cited by 1,968
Parkinson disease-associated cognitive impairment
Aarsland, D., Batzu, L., Halliday, G. M., Geurtsen, G. J., Ballard, C., Ray Chaudhuri, K., & Weintraub, D. (2021) · Nature Reviews Disease Primers · doi:10.1038/s41572-021-00280-3 · Cited by 1,371
Colonic bacterial composition in Parkinson's disease
Keshavarzian, A., Green, S. J., Engen, P. A., Voigt, R. M., Naqib, A., Forsyth, C. B., Mutlu, E., & Shannon, K. M. (2015) · Movement Disorders · doi:10.1002/mds.26307 · Cited by 1,281
The genetic architecture of Parkinson's disease
Blauwendraat, C., Nalls, M. A., & Singleton, A. B. (2020) · The Lancet Neurology · doi:10.1016/s1474-4422(19)30287-x · Cited by 1,114
Towards fog-driven IoT eHealth: Promises and challenges of IoT in medicine and healthcare
Farahani, B., Firouzi, F., Chang, V., Badaroglu, M., Constant, N., & Mankodiya, K. (2018) · Future Generation Computer Systems · doi:10.1016/j.future.2017.04.036 · Cited by 983
Depression rating scales in Parkinson's disease: Critique and recommendations
Schrag, A., Barone, P., Brown, R. G., Leentjens, A. F. G., McDonald, W. M., Starkstein, S., Weintraub, D., Poewe, W., Rascol, O., Sampaio, C., et al. (2007) · Movement Disorders · doi:10.1002/mds.21333 · Cited by 683
Self-citationParkinson's disease: Mechanisms, translational models and management strategies
Raza, C., Anjum, R., & Shakeel, N. U. A. (2019) · Life Sciences · doi:10.1016/j.lfs.2019.03.057 · Cited by 603
Cognitive status correlates with neuropathologic stage in Parkinson disease
Braak, H., Rüb, U., Jansen Steur, E. N. H., Del Tredici, K., & de Vos, R. A. I. (2005) · Neurology · doi:10.1212/01.wnl.0000158422.41380.82 · Cited by 560
Qin, X.-Y., Zhang, S.-P., Cao, C., Loh, Y. P., & Cheng, Y. (2016) · JAMA Neurology · doi:10.1001/jamaneurol.2016.2742 · Cited by 554
Schenkman, M., Moore, C. G., Kohrt, W. M., Hall, D. A., Delitto, A., Comella, C. L., Josbeno, D. A., Christiansen, C. L., Berman, B. D., Kluger, B. M., et al. (2018) · JAMA Neurology · doi:10.1001/jamaneurol.2017.3517 · Cited by 515
Self-citationMaiti, P., Manna, J., & Dunbar, G. L. (2017) · Translational Neurodegeneration · doi:10.1186/s40035-017-0099-z · Cited by 525
Role of TLR4 in the gut-brain axis in Parkinson's disease: A translational study from men to mice
Perez-Pardo, P., Dodiya, H. B., Engen, P. A., Forsyth, C. B., Huschens, A. M., Shaikh, M., Voigt, R. M., Naqib, A., Green, S. J., Kordower, J. H., et al. (2019) · Gut · doi:10.1136/gutjnl-2018-316844 · Cited by 467
Mirelman, A., Rochester, L., Maidan, I., Del Din, S., Alcock, L., Nieuwhof, F., Rikkert, M. O., Bloem, B. R., Pelosin, E., Avanzino, L., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)31325-3 · Cited by 493
Self-citationRhythmic auditory stimulation modulates gait variability in Parkinson’s disease
Hausdorff, J. M., Lowenthal, J., Herman, T., Gruendlinger, L., Peretz, C., & Giladi, N. (2007) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2007.05810.x · Cited by 489
Self-citationShahnawaz, M., Tokuda, T., Waragai, M., Mendez, N., Ishii, R., Trenkwalder, C., Mollenhauer, B., & Soto, C. (2017) · JAMA Neurology · doi:10.1001/jamaneurol.2016.4547 · Cited by 489
Validation of the freezing of gait questionnaire in patients with Parkinson’s disease
Giladi, N., Tal, J., Azulay, T., Rascol, O., Brooks, D. J., Melamed, E., Oertel, W., Poewe, W. H., Stocchi, F., & Tolosa, E. (2009) · Movement Disorders · doi:10.1002/mds.21745 · Cited by 431
Self-citationLi, W., Wu, X., Hu, X., Wang, T., Liang, S., Duan, Y., Jin, F., & Qin, B. (2017) · Science China Life Sciences · doi:10.1007/s11427-016-9001-4 · Cited by 406
Clinical Approach to Parkinson's Disease: Features, Diagnosis, and Principles of Management
Massano, J., & Bhatia, K. P. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a008870 · Cited by 422
Determinants of health-related quality of life in Parkinson’s disease: A systematic review
Soh, S.-E., Morris, M. E., & McGinley, J. L. (2011) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2010.08.012 · Cited by 386
Pompeu, J. E., Mendes, F. A. D. S., Silva, K. G. D., Lobo, A. M., Oliveira, T. D. P., Zomignani, A. P., & Piemonte, M. E. P. (2012) · Physiotherapy · doi:10.1016/j.physio.2012.06.004 · Cited by 354
Plotnik, M., Giladi, N., & Hausdorff, J. M. (2007) · Experimental Brain Research · doi:10.1007/s00221-007-0955-7 · Cited by 363
Self-citationParkinson's disease severity levels and MDS-Unified Parkinson's Disease Rating Scale
Martínez-Martín, P., Rodríguez-Blázquez, C., Alvarez, M., Arakaki, T., Arillo, V. C., Chaná, P., Fernández, W., Garretto, N., Martínez-Castrillo, J. C., Rodríguez-Violante, M., et al. (2015) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2014.10.026 · Cited by 360
Minimal clinically important difference on the Motor Examination part of MDS-UPDRS
Horváth, K., Aschermann, Z., Ács, P., Deli, G., Janszky, J., Komoly, S., Balázs, É., Takács, K., Karádi, K., & Kovács, N. (2015) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2015.10.006 · Cited by 348
Leddy, A. L., Crowner, B. E., & Earhart, G. M. (2011) · Physical Therapy · doi:10.2522/ptj.20100113 · Cited by 321
Feng, H., Li, C., Liu, J., Wang, L., Ma, J., Li, G., Gan, L., Shang, X., & Wu, Z. (2019) · Medical Science Monitor · doi:10.12659/msm.916455 · Cited by 306
Gandolfi, M., Geroin, C., Dimitrova, E., Boldrini, P., Waldner, A., Bonadiman, S., Picelli, A., Regazzo, S., Stirbu, E., Primon, D., et al. (2017) · BioMed Research International · doi:10.1155/2017/7962826 · Cited by 304
Leddy, A. L., Crowner, B. E., & Earhart, G. M. (2011) · Journal of Neurologic Physical Therapy · doi:10.1097/npt.0b013e31821a620c · Cited by 298
Del Tredici, K., Hawkes, C. H., Ghebremedhin, E., & Braak, H. (2010) · Acta Neuropathologica · doi:10.1007/s00401-010-0665-2 · Cited by 295
Meltzer, H. Y., Mills, R., Revell, S., Williams, H., Johnson, A., Bahr, D., & Friedman, J. H. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2009.176 · Cited by 292
Fatigue in Parkinson's disease: A systematic review and meta‐analysis
Siciliano, M., Trojano, L., Santangelo, G., De Micco, R., Tedeschi, G., & Tessitore, A. (2018) · Movement Disorders · doi:10.1002/mds.27461 · Cited by 291
Winder-Rhodes, S. E., Evans, J. R., Ban, M., Mason, S. L., Williams-Gray, C. H., Foltynie, T., Duran, R., Mencacci, N. E., Sawcer, S. J., & Barker, R. A. (2013) · Brain · doi:10.1093/brain/aws318 · Cited by 290
Antonini, A., Stoessl, A. J., Kleinman, L. S., Skalicky, A. M., Marshall, T. S., Sail, K. R., Onuk, K., & Odin, P. L. A. (2018) · Current Medical Research and Opinion · doi:10.1080/03007995.2018.1502165 · Cited by 282
Caregiver burden in Parkinson's disease
Martínez‐Martín, P., Forjaz, M. J., Frades‐Payo, B., Rusiñol, A. B., Fernández‐García, J. M., Benito‐León, J., Arillo, V. C., Barberá, M. A., Sordo, M. P., & Catalán, M. J. (2007) · Movement Disorders · doi:10.1002/mds.21355 · Cited by 279
Kustrimovic, N., Comi, C., Magistrelli, L., Rasini, E., Legnaro, M., Bombelli, R., Aleksic, I., Blandini, F., Minafra, B., Riboldazzi, G., et al. (2018) · Journal of Neuroinflammation · doi:10.1186/s12974-018-1248-8 · Cited by 278
Effect of Balance Training on Postural Instability in Patients With Idiopathic Parkinson’s Disease
Smania, N., Corato, E., Tinazzi, M., Stanzani, C., Fiaschi, A., Girardi, P., & Gandolfi, M. (2010) · Neurorehabilitation and Neural Repair · doi:10.1177/1545968310376057 · Cited by 271
Course in Parkinson disease subtypes: A 39-year clinicopathologic study
Rajput, A. H., Voll, A., Rajput, M. L., Robinson, C. A., & Rajput, A. (2009) · Neurology · doi:10.1212/wnl.0b013e3181ae7af1 · Cited by 270
GBA-associated PD presents with nonmotor characteristics
Brockmann, K., Srulijes, K., Hauser, A.-K., Schulte, C., Csoti, I., Gasser, T., & Berg, D. (2011) · Neurology · doi:10.1212/wnl.0b013e318225ab77 · Cited by 268
Brockmann, K., Srulijes, K., Pflederer, S., Hauser, A., Schulte, C., Maetzler, W., Gasser, T., & Berg, D. (2015) · Movement Disorders · doi:10.1002/mds.26071 · Cited by 267
CSF Multianalyte Profile Distinguishes Alzheimer and Parkinson Diseases
Zhang, J., Sokal, I., Peskind, E. R., Quinn, J. F., Jankovic, J., Kenney, C., Chung, K. A., Millard, S. P., Nutt, J. G., & Montine, T. J. (2008) · American Journal of Clinical Pathology · doi:10.1309/w01y0b808emeh12l · Cited by 264
Specifically neuropathic Gaucher's mutations accelerate cognitive decline in Parkinson's
Liu, G., Boot, B., Locascio, J. J., Jansen, I. E., Winder‐Rhodes, S., Eberly, S., Elbaz, A., Brice, A., Ravina, B., van Hilten, J. J., et al. (2016) · Annals of Neurology · doi:10.1002/ana.24781 · Cited by 263
Poletti, M., Enrici, I., & Adenzato, M. (2012) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2012.07.004 · Cited by 258
Martinez-Martin, P., Rodriguez-Blazquez, C., Alvarez-Sanchez, M., Arakaki, T., Bergareche-Yarza, A., Chade, A., Garretto, N., Gershanik, O., Kurtis, M. M., Martinez-Castrillo, J. C., et al. (2013) · Journal of Neurology · doi:10.1007/s00415-012-6624-1 · Cited by 252
Self-citationGardner, J. (2013) · Social Studies of Science · doi:10.1177/0306312713483678 · Cited by 243
Comprehensive metabolic profiling of Parkinson’s disease by liquid chromatography-mass spectrometry
Shao, Y., Li, T., Liu, Z., Wang, X., Xu, X., Li, S., Xu, G., & Le, W. (2021) · Molecular Neurodegeneration · doi:10.1186/s13024-021-00425-8 · Cited by 226
Benefits of physical exercise on executive functions in older people with Parkinson's disease
Tanaka, K., Quadros, A. C. D., Santos, R. F., Stella, F., Gobbi, L. T. B., & Gobbi, S. (2009) · Brain and Cognition · doi:10.1016/j.bandc.2008.09.008 · Cited by 221
Clinical Features of Parkinson’s Disease: The Evolution of Critical Symptoms
Váradi, C. (2020) · Biology · doi:10.3390/biology9050103 · Cited by 196
Evaluation of fecal microbiota transplantation in Parkinson's disease patients with constipation
Kuai, X.-Y., Yao, X.-H., Xu, L.-J., Zhou, Y.-Q., Zhang, L.-P., Liu, Y., Pei, S.-F., & Zhou, C.-L. (2021) · Microbial Cell Factories · doi:10.1186/s12934-021-01589-0 · Cited by 179
Gut Microbiota Differs Between Parkinson’s Disease Patients and Healthy Controls in Northeast China
Li, C., Cui, L., Yang, Y., Miao, J., Zhao, X., Zhang, J., Cui, G., & Zhang, Y. (2019) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2019.00171 · Cited by 178
Prevalence of small intestinal bacterial overgrowth in Parkinson’s disease
Gabrielli, M., Bonazzi, P., Scarpellini, E., Bendia, E., Lauritano, E. C., Fasano, A., Ceravolo, M. G., Capecci, M., Rita Bentivoglio, A., Provinciali, L., et al. (2011) · Movement Disorders · doi:10.1002/mds.23566 · Cited by 175
DuPont, H. L., Suescun, J., Jiang, Z.-D., Brown, E. L., Essigmann, H. T., Alexander, A. S., DuPont, A. W., Iqbal, T., Utay, N. S., Newmark, M., et al. (2023) · Frontiers in Neurology · doi:10.3389/fneur.2023.1104759 · Cited by 162
Chahine, L. M., Qiang, J., Ashbridge, E., Minger, J., Yearout, D., Horn, S., Colcher, A., Hurtig, H. I., Lee, V. M.-Y., Van Deerlin, V. M., et al. (2013) · JAMA Neurology · doi:10.1001/jamaneurol.2013.1274 · Cited by 150
Probiotics may have beneficial effects in parkinson’s disease: In vitro evidence
Magistrelli, L., Amoruso, A., Mogna, L., Graziano, T., Cantello, R., Pane, M., & Comi, C. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00969 · Cited by 144
García, A. M., Carrillo, F., Orozco-Arroyave, J. R., Trujillo, N., Vargas Bonilla, J. F., Fittipaldi, S., Adolfi, F., Nöth, E., Sigman, M., Fernández Slezak, D., et al. (2016) · Brain and Language · doi:10.1016/j.bandl.2016.07.008 · Cited by 144
Nonmotor gastrointestinal disorders in older patients with Parkinson’s disease: is there hope?
Georgescu, D., Ancusa, O., Georgescu, L., Ionita, I., & Reisz, D. (2016) · Clinical Interventions in Aging · doi:10.2147/cia.s106284 · Cited by 138
Wennström, M., Surova, Y., Hall, S., Nilsson, C., Minthon, L., Boström, F., Hansson, O., & Nielsen, H. M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0053250 · Cited by 141
Reinertsen, E., & Clifford, G. D. (2018) · Physiological Measurement · doi:10.1088/1361-6579/aabf64 · Cited by 136
Boxing training for patients with Parkinson disease: a case series
Combs, S. A., Diehl, M. D., Staples, W. H., Conn, L., Davis, K., Lewis, N., & Schaneman, K. (2011) · Physical Therapy · doi:10.2522/ptj.20100142 · Cited by 135
Motor learning benefits of self-controlled practice in persons with Parkinson's disease
Chiviacowsky, S., Wulf, G., Lewthwaite, R., & Campos, T. (2012) · Gait & Posture · doi:10.1016/j.gaitpost.2011.12.003 · Cited by 127
Toosizadeh, N., Mohler, J., Lei, H., Parvaneh, S., Sherman, S., & Najafi, B. (2015) · PLOS ONE · doi:10.1371/journal.pone.0124763 · Cited by 117
Liu, G., Peng, J., Liao, Z., Locascio, J. J., Corvol, J.-C., Zhu, F., Dong, X., Maple-Grødem, J., Campbell, M. C., Elbaz, A., et al. (2021) · Nature Genetics · doi:10.1038/s41588-021-00847-6 · Cited by 127
Fecal microbiota transplant as a potential treatment for Parkinson's disease – A case series
Segal, A., Zlotnik, Y., Moyal-Atias, K., Abuhasira, R., & Ifergane, G. (2021) · Clinical Neurology and Neurosurgery · doi:10.1016/j.clineuro.2021.106791 · Cited by 124
Theodoros, D. G., Hill, A. J., & Russell, T. G. (2016) · American Journal of Speech-Language Pathology · doi:10.1044/2015_ajslp-15-0005 · Cited by 110
The Clinical Evaluation of Parkinson’s Tremor
Zach, H., Dirkx, M., Bloem, B. R., & Helmich, R. C. (2015) · Journal of Parkinson's Disease · doi:10.3233/jpd-150650 · Cited by 113
Paknahad, Z., Sheklabadi, E., Derakhshan, Y., Bagherniya, M., & Chitsaz, A. (2020) · Complementary Therapies in Medicine · doi:10.1016/j.ctim.2020.102366 · Cited by 113
Dumitrescu, L., Marta, D., Dănău, A., Lefter, A., Tulbă, D., Cozma, L., Manole, E., Gherghiceanu, M., Ceafalan, L. C., & Popescu, B. O. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.689723 · Cited by 100
Using a smartwatch and smartphone to assess early Parkinson’s disease in the WATCH-PD study
Adams, J. L., Kangarloo, T., Tracey, B., O’Donnell, P., Volfson, D., Latzman, R. D., Zach, N., Alexander, R., Bergethon, P., Cosman, J., et al. (2023) · npj Parkinson's Disease · doi:10.1038/s41531-023-00497-x · Cited by 98
Mihaila, D., Donegan, J., Barns, S., LaRocca, D., Du, Q., Zheng, D., Vidal, M., Neville, C., Uhlig, R., & Middleton, F. A. (2019) · PLOS ONE · doi:10.1371/journal.pone.0218252 · Cited by 94
Li, N., Pan, X., Zhang, J., Ma, A., Yang, S., Ma, J., & Xie, A. (2017) · Neurological Sciences · doi:10.1007/s10072-017-2841-9 · Cited by 97
Schenkman, M., Ellis, T., Christiansen, C., Barón, A. E., Tickle-Degnen, L., Hall, D. A., & Wagenaar, R. (2011) · Physical Therapy · doi:10.2522/ptj.20100236 · Cited by 85
Fonseca, L. C., Tedrus, G. M. A. S., Carvas, P. N., & Machado, E. C. F. A. (2013) · Clinical Neurophysiology · doi:10.1016/j.clinph.2013.05.001 · Cited by 85
Fiorelli, C. M., Ciolac, E. G., Simieli, L., Silva, F. A., Fernandes, B., Christofoletti, G., & Barbieri, F. A. (2019) · Journal of Physical Activity and Health · doi:10.1123/jpah.2018-0189 · Cited by 72
Assessments of plasma ghrelin levels in the early stages of Parkinson's disease
Song, N., Wang, W., Jia, F., Du, X., Xie, A., He, Q., Shen, X., Zhang, J., Rogers, J. T., Xie, J., et al. (2017) · Movement Disorders · doi:10.1002/mds.27095 · Cited by 67
Yang, Z., Tian, Y., Fan, Y., Liu, L., Luo, Y., Zhou, L., & Yu, H. (2019) · Journal of Affective Disorders · doi:10.1016/j.jad.2019.05.064 · Cited by 66
Prevalence of small intestinal bacterial overgrowth in Chinese patients with Parkinson's disease
Niu, X.-L., Liu, L., Song, Z.-X., Li, Q., Wang, Z.-H., Zhang, J.-L., & Li, H.-H. (2016) · Journal of Neural Transmission · doi:10.1007/s00702-016-1612-8 · Cited by 64
Urolithins: Potential Biomarkers of Gut Dysbiosis and Disease Stage in Parkinson’s Patients
Romo-Vaquero, M., Fernández-Villalba, E., Gil-Martinez, A.-L., Cuenca-Bermejo, L., Espín, J. C., Herrero, M. T., & Selma, M. V. (2022) · Food & Function · doi:10.1039/d2fo00552b · Cited by 54
Acumulative genetic risk score predicts progression in Parkinson's disease
Pihlstrøm, L., Morset, K. R., Grimstad, E., Vitelli, V., & Toft, M. (2016) · Movement Disorders · doi:10.1002/mds.26505 · Cited by 52
Voigt, R. M., Wang, Z., Brown, J. M., Engen, P. A., Naqib, A., Goetz, C. G., Hall, D. A., Metman, L. V., Shaikh, M., Forsyth, C. B., et al. (2022) · Neurobiology of Disease · doi:10.1016/j.nbd.2022.105780 · Cited by 51
Self-citationUsefulness of Screening Tools for Predicting Driving Performance in People With Parkinson’s Disease
Classen, S., Witter, D. P., Lanford, D. N., Okun, M. S., Rodriguez, R. L., Romrell, J., Malaty, I., & Fernandez, H. H. (2011) · American Journal of Occupational Therapy · doi:10.5014/ajot.2011.001073 · Cited by 49
The Single-Leg-Stance Test in Parkinson’s Disease
Chomiak, T., Pereira, F. V., & Hu, B. (2015) · Journal of Clinical Medicine Research · doi:10.14740/jocmr1878w · Cited by 49
A review of vitamin D and Parkinson's disease
Peterson, A. L. (2014) · Maturitas · doi:10.1016/j.maturitas.2014.02.012 · Cited by 48
Birtwell, K., Dubrow-Marshall, L., Dubrow-Marshall, R., Duerden, T., & Dunn, A. (2017) · Complementary Therapies in Clinical Practice · doi:10.1016/j.ctcp.2017.10.009 · Cited by 46
Son, H. G., & Choi, E.-O. (2018) · Asian Nursing Research · doi:10.1016/j.anr.2018.06.001 · Cited by 46
Eyigoz, E., Courson, M., Sedeño, L., Rogg, K., Orozco-Arroyave, J. R., Nöth, E., Skodda, S., Trujillo, N., Rodríguez, M., Rusz, J., et al. (2020) · Cortex · doi:10.1016/j.cortex.2020.08.020 · Cited by 44
Fernandes, B., Barbieri, F. A., Arthuso, F. Z., Silva, F. A., Moretto, G. F., Imaizumi, L. F. I., Ngomane, A. Y., Guimarães, G. V., & Ciolac, E. G. (2020) · Journal of Physical Activity and Health · doi:10.1123/jpah.2018-0588 · Cited by 42
A Systematic Review of Parkinson’s Disease Cluster Analysis Research
Hendricks, R. M., & Khasawneh, M. T. (2021) · Aging and disease · doi:10.14336/ad.2021.0519 · Cited by 40
Changes in Gastrointestinal Microbiome Composition in PD: A Pivotal Role of Covariates
Cosma-Grigorov, A., Meixner, H., Mrochen, A., Wirtz, S., Winkler, J., & Marxreiter, F. (2020) · Frontiers in Neurology · doi:10.3389/fneur.2020.01041 · Cited by 38
Yu, C.-C., Chen, H.-L., Chen, M.-H., Lu, C.-H., Tsai, N.-W., Huang, C.-C., Chang, Y.-Y., Li, S.-H., Chen, Y.-S., Chiang, P.-L., et al. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/2591248 · Cited by 37
Jones, C. A., Hoffman, M. R., Lin, L., Abdelhalim, S., Jiang, J. J., & McCulloch, T. M. (2018) · Neurogastroenterology & Motility · doi:10.1111/nmo.13236 · Cited by 35
Staging Neurodegenerative Disorders: Structural, Regional, Biomarker, and Functional Progressions
Archer, T., Kostrzewa, R. M., Beninger, R. J., & Palomo, T. (2011) · Neurotoxicity Research · doi:10.1007/s12640-010-9190-2 · Cited by 34
The Psychometric Properties of the Voice Handicap Index in People With Parkinson's Disease
Guimaraes, I., Cardoso, R., Pinto, S., & Ferreira, J. J. (2017) · Journal of Voice · doi:10.1016/j.jvoice.2016.05.017 · Cited by 35
Lebrun, C., Gély‐Nargeot, M., Rossignol, A., Geny, C., & Bayard, S. (2020) · Journal of Clinical Psychology · doi:10.1002/jclp.22883 · Cited by 32
Park, Y., Kim, S. R., So, H. Y., Jo, S., Lee, S. H., Hwang, Y. S., Kim, M. S., & Chung, S. J. (2022) · Geriatric Nursing · doi:10.1016/j.gerinurse.2022.05.003 · Cited by 30
Deep Nasal Sinus Cavity Microbiota Dysbiosis in Parkinson’s Disease
Pal, G., Ramirez, V., Engen, P. A., Naqib, A., Forsyth, C. B., Green, S. J., Mahdavinia, M., Batra, P. S., Tajudeen, B. A., & Keshavarzian, A. (2021) · npj Parkinson s Disease · doi:10.1038/s41531-021-00254-y · Cited by 28
Opportunities and challenges for biomarker discovery using electronic health record data
Singhal, P., Tan, A. L. M., Drivas, T. G., Johnson, K. B., Ritchie, M. D., & Beaulieu-Jones, B. K. (2023) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2023.06.006 · Cited by 21
Circular RNAs in Parkinson’s Disease: Reliable Biological Markers and Targets for Rehabilitation
Duan, Y., Wang, Y., Liu, Y., Jin, Z., Liu, C., Yu, X., Chen, K., Meng, D., Xi, J., & Fang, B. (2023) · Molecular Neurobiology · doi:10.1007/s12035-023-03268-0 · Cited by 17
Weber, I., Zagona-Prizio, C., Sivesind, T. E., Adelman, M., Szeto, M. D., Liu, Y., Sillau, S. H., Bainbridge, J., Klawitter, J., Sempio, C., et al. (2024) · JMIR Dermatology · doi:10.2196/49965 · Cited by 7
Amplitude and velocity dependence of patellar pendulum triggered by T reflex in Parkinson’s rigidity
Uslu, S., Gürbüz, M., Kızılay, F., Özkaynak, S., Nüzket, T., & Uysal, H. (2021) · Neurological Sciences · doi:10.1007/s10072-020-04936-y · Cited by 5
Metadata
- Authors
- Goetz, C. G., Poewe, W., Rascol, O., Sampaio, C., Stebbins, G. T., Counsell, C., Giladi, N., Holloway, R. G., Moore, C. G., Wenning, G. K., Yahr, M. D., & Seidl, L.
- Venue
- Movement Disorders
- Publisher
- Wiley
- Published
- 2004-08-30
- Volume
- 19
- Issue
- 9
- Pages
- 1020-1028
- ISSN
- 0885-3185 (ISSN-L)
- 1531-8257
- OpenAlex
- W2126008330
- Cited by
- 2,347
- References
- 44
- FWCI
- 7.59
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.